IFNA2 and infection: When compared to the mock-treated controls, fold reductions in pre-infection and post-infection time frames were 16-fold (IFN-αK), 14-fold (IFN-αWA) and 3-fold (IFN-α2a) (Fig 3, grey bars) and, 132-fold (IFN-αK p<0.01), 37-fold (IFN-αWA p<0.01) and 6-fold (IFN-α2a p<0.1) (Fig 3, black bars), respectively.